MRNA
Moderna·NASDAQ
--
--(--)
--
--(--)
5.73 / 10
Netural
Sentiment is neutral (5.73/10) but fund‑flow is good (7.75/10), driven by small‑cap buying and larger‑cap outflows. Analyst ratings are 25% Buy, 75% Neutral with mixed historical success, supporting a cautiously optimistic but watchful perspective.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
25%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-17
InstitutionEvercore ISI Group
Times predicted2
Historical Win Rate50.0%
What is the market sentiment for MRNA?
- MRNA holds a Bearish analyst rating, with 25% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.73/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
